Summer 2026
Acquisitions Editorial Assistant Intern
Posted on 4/30/2026
Elsevier
10,001+ employees
Global STM publisher of journals.
No salary listed
Remote in UK
Remote
 Product (1) |
|---|
Get referred to Elsevier
See people who can refer or advise you
- A passion for science communication, publishing, and the dissemination of knowledge
- A demonstrated commitment to inclusion, equity, and belonging
- Ability to adapt communication style for different audiences
- Familiarity with MS Office tools, especially MS Word, Excel and PowerPoint
- Strong organizational, time management, communication, and teamwork skills
- Learn about Foundational Content product types and customer needs
- Research a focused signing area and target key textbook topics for prospecting
- Use inhouse data and analytics tools to identify and contact qualified reviewers and authors, and build pipeline for new textbook projects
- Utilize in-house AI tools to support aspects of the acquisitions process
- Support inclusion initiatives in author recruitment
- Prepare textbook proposals for formal approval
- Assist in setting up and attending virtual editorial board meetings
- Network and collaborate with colleagues across content delivery, production, and more
Elsevier provides scientific, medical, and technical content and analytics to researchers, educators, clinicians, and institutions worldwide through journals, books, databases, and digital platforms. It operates by offering access to peer-reviewed articles and professional literature via online platforms, along with tools for discovery, citation tracking, research management, and clinical decision support. Unlike other publishers, Elsevier combines a broad portfolio of STM content with integrated analytics and workflow tools, serving researchers, healthcare professionals, and academic institutions on a global scale. Its goal is to enable the advancement of knowledge and improve health outcomes by delivering reliable, accessible information and data-driven solutions across the research lifecycle.
Company Size
10,001+
Company Stage
N/A
Total Funding
N/A
Headquarters
Amsterdam, Netherlands
Founded
1880
Get referred to Elsevier
See people who can refer or advise you
Simplify's Take
What believers are saying
- July 2, 2026 CzechELib and February 23, 2026 Jisc deals expand access revenue.
- June 25, 2026 LeapSpace added agentic tools across 20 million articles.
- ClinicalKey AI and StudyFinder AI upgrades deepen healthcare education and hospital adoption.
What critics are saying
- The May 2026 Meta copyright lawsuit ties growth to disputed training rights.
- Read-and-publish deals with Jisc and CzechELib squeeze journal economics through 2027.
- Open-access mandates and AI search tools can route users around Elsevier paywalls.
What makes Elsevier unique
- Elsevier owns Scopus, ClinicalKey, and ScienceDirect across research and care workflows.
- Its traceable medical AI cites peer-reviewed sources, unlike generic chatbots.
- June 2026 Wellsheet integration embeds clinical evidence directly inside EHRs.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Unlimited Paid Time Off
Flexible Work Hours
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Employee Assistance Program
Short-and-Long Term Disability
Life Insurance
Accidental Death Insurance
Wellness Program
Family Planning Benefits
Fertility Treatment Support
Health Savings Account/Flexible Spending Account
Company News
Elsevier's LeapSpace wins best generative AI solution at CODiE Awards. 23 July 2026 Elsevier's AI-powered research platform, LeapSpace, has been named Best Generative AI Solution at the 2026 CODiE Awards. The CODiE Awards, established in 1986, are among the technology industry's longest-running peer-reviewed awards programmes, recognising companies, products and leaders across software, AI, data, cybersecurity and digital learning. LeapSpace is Elsevier's research-focused AI workspace, designed to support both academic and corporate researchers. The platform combines publisher-neutral scholarly content with AI-powered tools including traceable citations, Trust Cards, Claim Radar and Writing Coach to help researchers explore evidence, validate outputs and accelerate research workflows. Elsevier says the platform has been developed in collaboration with customers to ensure it continues to meet the evolving needs of the research community. Judy Verses, President, Academic and Government, Elsevier, said: "This CODiE Award is a testament to what makes LeapSpace different. Researchers need more than generic AI. They need trusted evidence, clear citations, transparent reasoning, and control over how insights are interpreted and used. LeapSpace was built with customers' needs at its core, and this recognition reflects the dedication of our colleagues who developed the solution and the customers and research communities who continue to shape it with us." The platform has been designed to address growing demand for AI tools that are built on trusted scientific content, provide transparency in how outputs are generated and enable researchers to maintain oversight of their work. Dr. Sunil Kumar Satpathy, Head of the Central Library, National Institute of Technology Raipur, India, said: "LeapSpace helps researchers overcome intense time pressure, information overload, and missed insights. It boosts efficiency in literature reviews, supports mission-oriented research, and helps identify research gaps and trends. Our researchers appreciate that LeapSpace provides comprehensive, peer-reviewed content and responsible AI in one place." The CODiE Awards use a peer-reviewed judging process combining expert evaluation with community voting to recognise excellence across a range of technology sectors.
Elsevier signs first CzechELib open access agreement. 2 July 2026 Elsevier has signed its first agreement with the CzechELib consortium, led by National Library of Technology of the Czech Republic. The five-year agreement enables eligible corresponding authors at participating CzechELib institutions to publish open access in selected Elsevier hybrid journals without paying article publishing charges (APCs). The publisher said the agreement marks an important milestone in its relationship with the Czech research community and supports the country's transition towards open science. "The agreement enables researchers to publish in high-quality journals while removing financial barriers associated with open access," said Petr Očko, Director of the National Library of Technology. Under the agreement, eligible corresponding authors affiliated with participating CzechELib institutions will be able to publish open access in selected hybrid journals, with APCs covered through the agreement. Elsevier said the partnership is intended to support wider dissemination of Czech research, simplify the publishing process for researchers and institutions, and contribute to national open science priorities. William Reubens said: "We are proud to establish our first agreement with CzechELib and to begin this partnership as a trusted partner to the Czech research community. This agreement provides researchers with a clear and supported route to publishing open access in leading journals, helping to increase the visibility and impact of their work while removing financial and administrative barriers." Jiří Jirát added: "This first agreement with Elsevier represents an important step forward for the Czech research community. By working together as trusted partners, we are enabling greater access to open access publishing and supporting researchers in sharing their work more widely on a global stage. During the first few months of the agreement, authors from all types of institutions have already shown great interest in publishing under it."
Elsevier has expanded LeapSpace, its research-grade AI workspace, with new agentic capabilities including Writing Coach, Claim Radar and Compare Tables. The platform draws on over 20 million peer-reviewed articles and books from Elsevier and 1,000 content partners, plus 100 million scientific records from Scopus. Writing Coach provides a private space for drafting and refining research work with AI assistance, whilst Claim Radar verifies evidence by assessing how claims align with published literature. Compare Tables automates literature comparison work by extracting evidence into structured formats. LeapSpace is already used by thousands of researchers globally, with 97% reporting time savings and over half saving more than 50% of research time. The platform also now supports Word document uploads and reference exports, addressing key user requests.
Elsevier's ClinicalKey Student adds StudyFinder AI to quickly connect medical students to trusted, verifiable content for more efficient studying. June 25, 2026 The addition of StudyFinder AI and Osmosis AI combines trusted content from books, videos and 3D models with user-centric AI to improve efficiency and productivity in medical education Elsevier has added StudyFinder AI to ClinicalKey Student to deliver trusted AI to medical education. 74%[1] of today's medical students already use AI to support their studies, but many generic tools provide unverified answers lacking context, accuracy and transparency. Building on the launch of Osmosis AI earlier this year, the addition of StudyFinder AI allows students to use ClinicalKey Student to access trusted, evidence-based content quicker and more efficiently than ever before. Addressing the growing demand for trusted AI in healthcare education, the enhanced ClinicalKey Student eliminates the risks often associated with generic AI alternatives. StudyFinder AI will initially be available in the UK, Australia and New Zealand, while Osmosis AI is currently available globally. Brent Gordon, President of Elsevier Healthcare Education, said: "Most AI tools available to students today lack answers supported by trusted and verifiable sources. ClinicalKey Student is different − every StudyFinder AI response is drawn from content that medical schools recommend, including Elsevier's evidence-based content, and is instantly verifiable. This is critical for students learning how to make clinical decisions." StudyFinder AI supports medical students in the following ways: * AI-driven search capabilities allow students to study more efficiently, quickly connecting them to trusted, curriculum-aligned resources * Embedded citations mean students can be confident they are using verified sources when studying * Allows students to ask questions and search topics, visualize with 2D and 3D models, and create visual aids for studying * Allows students to draw from a curated selection of evidence-based textbooks, over 6,000 multiple-choice questions and over 1,000 bite-sized videos Nadya Affendy, a current UK medical student, said:"A key part of medicine is evidence-based learning which isn't guaranteed by a lot of AI tools. That's what stood out about StudyFinder; the AI bases itself off of trusted sources from Elsevier textbooks, as well as the NICE guidelines - the same kind of textbooks which are recommended by professors and lecturers throughout medical school." The announcement follows the launch of Osmosis AI in March this year, which provides the following capabilities: * Combines award-winning Osmosis videos, trusted Elsevier medical content (including the most authoritative textbooks) and responsible AI to provide timely support for students and educators * Connects answers directly to Osmosis videos students already rely on, and provides clear citations for verification * Prioritises high yield, clinically relevant explanations aligned with medical curricula and board exams Elsevier Healthcare Education also plans to launch its AI-powered Assessment Creator this summer in select markets as part of a new enterprise solution for medical education, saving faculty valuable time when creating curriculum-aligned, evidence-based assessments. Find out more about ClinicalKey Student here. [1] Internal research study of 250 medical students (2025) About Elsevier. Elsevier is a global leader in advanced information and decision support. For over a century, Elsevier has been helping advance science and healthcare to advance human progress. Elsevier support academic and corporate research communities, doctors, nurses, future healthcare professionals, and educators across 170 countries in their vital work. Elsevier help impact makers achieve better outcomes with research and clinical-grade solutions built on the world's leading evidence-based scientific and medical content, precision AI, and expert human assessment. Elsevier champion inclusion and sustainability, working with the communities that Elsevier serve. The Elsevier Foundationopens in new tab/window supports research and health partnerships around the world. Elsevier is part of RELXopens in new tab/window, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow Elsevier on social media @elsevierconnect.
8th International Symposium Frontiers in Polymer Science. Prof. Haritz Sardon and Dr. Xabi Lopez de Pariza recently participated in the Elsevier event, the Eighth International Symposium Frontiers in Polymer Science, held in Chengdu, China, from 11 to 14 June 2026. Haritz Sardon Lab is delighted to announce that both researchers received prestigious recognition for their outstanding contributions. Prof. Sardon was awarded for his invited lecture, From Recycling Legacy Plastics to Designing Functional Plastics with Circularity, presented on Friday, 12 June. Dr. Lopez de Priza received the Best Poster Award for his presentation entitled Standardizing Light: A Modular Photoreactor for Controlled, Reproducible and High-Throughput Photochemical Reactions. Congratulations to both on these well-deserved achievements, and Haritz Sardon Lab wish them continued success in their research endeavors!